Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
14 Novembre 2024 - 4:19PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
One):
|
| Form 10-K |_| Form 11-K |_| Form 20-F |X| Form 10-Q
For
Period Ended: September 30, 2024
[
] Transition Report on Form 10-K
[
] Transition Report on Form 20-F
[
] Transition Report on Form 11-K
[
] Transition Report on Form 10-Q
[
] Transition Report on Form N-SAR
For
the Transition Period Ended: ____________________________
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ________________________
PART I
REGISTRANT INFORMATION
American Cannabis Company, Inc.
-----------------------------------------------
Full Name of Registrant
.
------------------------------------------------
Former Name if Applicable
1004 S Tejon Street
------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Colorado Springs, Colorado 80903
------------------------------------------------
City, State and Zip Code
PART
II
RULES
12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check appropriate box.)
[ ] | | (a)
The reasons described in reasonable detail in Part III of this form could not be eliminated
without unreasonable effort or expense; |
[x] | | (b)
The subject annual report, semi-annual report, transition report on Form 10-K, 20-F,
11-K or N-SAR, or portion thereof, will be filed on or before the 15th calendar day following
the prescribed due date; or the subject quarterly report or transition report on Form
10-Q or portion thereof will be filed on or before the fifth calendar day following the
prescribed due date; and |
[ ] | | (c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached
if applicable. |
PART
III
NARRATIVE
State
below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR, or the transition report or portion thereof, could
not be filed within the prescribed time period.
The
Company is unable to file its Form 10-Q within the prescribed period without unreasonable expense because management has not been
able to complete the adjustments necessary to close its books for the quarter end. The Company fully expects to be able to
file within the additional time allowed by this report.
PART
IV
OTHER
INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification
Mailander Law Office, Inc., Tad Mailander (619)
549-1442
(Name) (Area Code) (Telephone Number)
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file
such report(s) been filed? If answer is no, identify report(s). [ ] Yes [X] No
June
30, 2024
(3)
Is it anticipated that any significant change in results of operation for the corresponding period for the last fiscal year will
be reflected by the earnings statements to be included in the subject report or portion thereof? |__| Yes |X| No
American
Cannabis Company, Inc.
(Name
of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: |
November 14, 2024 |
|
By: |
/s/ Joseph Cleghorn |
|
|
|
|
Principal Executive Officer |
Instruction:
The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of
the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional
misstatements or omissions of fact constitute Federal criminal violations. (See 18 U.S.C. 1001)
American Cannabis (CE) (USOTC:AMMJ)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
American Cannabis (CE) (USOTC:AMMJ)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024